Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Dose Reduction in Psoriasis
NCT04028713Phase 4Terminated
- Sponsor
- Ghent University Hospital
- Start
- Feb 2021
- Primary completion
- Mar 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in plaque psoriasis, sponsored by Ghent University Hospital. Started Feb 2021; status: terminated.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04028713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028713.